文献速递炎症性肠病

临床前溃疡性结肠炎的系统性炎症特征

Systemic Inflammation in Preclinical Ulcerative Colitis.
PubMed 文献 · Gastroenterology · 2021-07-21

研究基于人群筛查队列,对日后发生溃疡性结肠炎者(n=72)与匹配健康对照(n=140)的血浆进行92种炎症相关蛋白检测,发现6种蛋白在临床前阶段即上调,并在独立起始队列中验证模型区分初治患者与对照的AUC为0.92。健康双胞胎同胞中部分蛋白亦上调,提示遗传与环境风险因素暴露时已存在炎症改变。

要点

  • 临床前溃疡性结肠炎存在系统性炎症蛋白上调,早于诊断数年。
  • MMP10、CXCL9、CCL11、SLAMF1、CXCL11和MCP-1在临床前阶段显著上调。
  • 多变量模型区分初治溃疡性结肠炎患者与对照的AUC达0.92。

核心结论

  • 一组炎症蛋白在溃疡性结肠炎诊断前数年即上调,对疾病诊断具有高度预测价值,部分蛋白在遗传与环境风险因素暴露时已升高。

研究设计与样本

  • 基于人群筛查队列,纳入日后发生溃疡性结肠炎者72例与匹配健康对照140例,采用邻位延伸分析检测92种炎症相关蛋白。
  • 在溃疡性结肠炎起始队列(患者101例、健康对照50例)中验证生物学相关性。
  • 在健康双胞胎同胞队列(患者同胞41例、匹配健康对照37例)中探索遗传与环境因素的影响。

主要发现

  • MMP10、CXCL9、CCL11、SLAMF1、CXCL11和MCP-1在临床前溃疡性结肠炎中较对照上调(P < .05),基于单变量和多变量模型均显著。
  • 通路分析识别出潜在关键调控因子,包括白细胞介素-1β、肿瘤坏死因子、干扰素-γ、制瘤素M、核因子-κB、白细胞介素-6和白细胞介素-4。
  • 在起始队列中构建的多变量模型通过留一交叉验证区分初治溃疡性结肠炎患者与对照的曲线下面积(AUC)为0.92。
  • 在健康双胞胎同胞中,MMP10、CXCL9、CXCL11和MCP-1显著上调,而CCL11和SLAMF1未显著上调,且这些蛋白在 incident 溃疡性结肠炎中相对丰度更高。

关键数值与推荐

  • 临床前溃疡性结肠炎中6种蛋白较对照上调,P < .05。
  • 多变量模型区分初治溃疡性结肠炎与对照的AUC = 0.92(留一交叉验证)。

临床怎么用

  • 炎症蛋白谱可能有助于在诊断前识别溃疡性结肠炎高风险个体,但需进一步验证后方可用于临床筛查。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Preclinical ulcerative colitis is poorly defined. We aimed to characterize the preclinical systemic inflammation in ulcerative colitis, using a comprehensive set of proteins. METHODS: We obtained plasma samples biobanked from individuals who developed ulcerative colitis later in life (n = 72) and matched healthy controls (n = 140) within a population-based screening cohort. We measured 92 proteins related to inflammation using a proximity extension assay. The biologic relevance of these findings was validated in an inception cohort of patients with ulcerative colitis (n = 101) and healthy controls (n = 50). To examine the influence of genetic and environmental factors on these markers, a cohort of healthy twin siblings of patients with ulcerative colitis (n = 41) and matched healthy controls (n = 37) were explored. RESULTS: Six proteins (MMP10, CXCL9, CCL11, SLAMF1, CXCL11 and MCP-1) were up-regulated (P < .05) in preclinical ulcerative colitis compared with controls based on both univariate and multivariable models. Ingenuity Pathway Analyses identified several potential key regulators, including interleukin-1β, tumor necrosis factor, interferon-gamma, oncostatin M, nuclear factor-κB, interleukin-6, and interleukin-4. For validation, we built a multivariable model to predict disease in the inception cohort. The model discriminated treatment-naïve patients with ulcerative colitis from controls with leave-one-out cross-validation (area under the curve = 0.92). Consistently, MMP10, CXCL9, CXCL11, and MCP-1, but not CCL11 and SLAMF1, were significantly up-regulated among the healthy twin siblings, even though their relative abundances seemed higher in incident ulcerative colitis. CONCLUSIONS: A set of inflammatory proteins are up-regulated several years before a diagnosis of ulcerative colitis. These proteins were highly predictive of an ulcerative colitis diagnosis, and some seemed to be up-regulated already at exposure to genetic and environmental risk factors.

来源:Gastroenterology,查看原文。版权归原作者所有。

引用

  1. Bergemalm D, Andersson E, Hultdin J, et al. Systemic Inflammation in Preclinical Ulcerative Colitis. Gastroenterology. 2021. PMID: 34298022. doi:10.1053/j.gastro.2021.07.026

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。